1. [P2–011]: INCREASED PRO‐INFLAMMATORY SIGNALING AND EVIDENCE OF ALZHEIMER's DISEASE PATHOLOGY IN HEALTHY OLDER ADULTS AT RISK FOR AD. (1st July 2017) Authors: Meyer, Pierre‐Francois; Poirier, Judes; Rosa‐Neto, Pedro; Weitz, Tara M.; Town, Terrence; Labonte, Anne; Breitner, John C.S. Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 12 Page Start: P608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O4‐11‐06: NSAIDS FOR AD PREVENTION? NAPROXEN ENTERS THE CNS WITHOUT APPARENT EFFECT ON CSF IMMUNE MARKERS. (1st July 2019) Authors: Meyer, Pierre-François; Labonte, Anne; Rosa-Neto, Pedro; Poirier, Judes; Breitner, John C.S. Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 24 Page Start: P1264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O1‐03‐06: EARLY INCREASE IN TAU‐PET SIGNAL IS ASSOCIATED WITH Aβ BURDEN, CSF P‐TAU LEVELS AND COGNITION IN COGNITIVELY NORMAL LATE‐MIDDLE‐AGED ADULTS. (1st July 2006) Authors: McSweeney, Melissa; Binette, Alexa Pichet; Meyer, Pierre-Francois; Gonneaud, Julie; Bedetti, Christophe; Ozlen, Hazal; Daoust, Leslie-Ann; Poirier, Judes; Rosa-Neto, Pedro; Breitner, John C.S.; Labonte, Anne; Villeneuve, Sylvia Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 4 Page Start: P222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. [P4–140]: HMG COA REDUCTASE IS A GENETIC MODIFIER FOR RISK, AGE OF ONSET AND ALZHEIMER's DISEASE's CONVERSION WHICH MODULATES PATHOLOGY‐RELATED AD BIOMARKERS. (1st July 2017) Authors: Dea, Doris; Théroux, Louise; Leduc, Valerie; Labonte, Anne; Nilsson, Nathalie I.V.; Poirier, Judes Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 27 Page Start: P1310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. IC‐P‐209: EARLY INCREASE IN TAU‐PET SIGNAL IS ASSOCIATED WITH Aβ BURDEN, CSF P‐TAU LEVELS AND COGNITION IN COGNITIVELY NORMAL LATE‐MIDDLE‐AGED ADULTS. (1st July 2006) Authors: McSweeney, Melissa; Binette, Alexa Pichet; Meyer, Pierre-Francois; Gonneaud, Julie; Bedetti, Christophe; Ozlen, Hazal; Daoust, Leslie-Ann; Labonte, Anne; Poirier, Judes; Rosa-Neto, Pedro; Breitner, John C.S.; Villeneuve, Sylvia Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 3 Page Start: P172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A blood cholesterol polygenic score in two independent AD cohorts: Genetics/genetic factors of Alzheimer's disease. (7th December 2020) Authors: Nilsson, Nathalie I.V.; Picard, Cynthia; Labonte, Anne; Poirier, Judes Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CSF apolipoprotein B is associated with early tau pathology and selective activation of a cytokine cascade in cognitively unaffected subjects with a parental history of Alzheimer's disease. (31st December 2021) Authors: Labonte, Anne; Picard, Cynthia; Nilsson, Nathalie I.V.; Rosa‐Neto, Pedro; Breitner, John; Villeneuve, Sylvia; Poirier, Judes Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 5 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗